Literature DB >> 26991828

Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.

Oliver Waidmann1, Friederike Brunner2, Eva Herrmann3, Stefan Zeuzem2, Albrecht Piiper2, Bernd Kronenberger2.   

Abstract

BACKGROUND & AIMS: Hepatocyte death is an important factor in development and progression of cirrhosis. Cytokeratin 18-based serum markers reflecting apoptotic (M30) and overall epithelial cell death (M65 and M65EpiDeath) have been used as prognostic parameters for survival in patients with acute liver failure. However, there has been no trial investigating M30, M65 and M65EpiDeath as survival parameters in patients with cirrhosis and acute-on-chronic liver failure.
METHODS: Patients with cirrhosis were enrolled and followed until death, liver transplantation or last contact. M30, M65 and M65EpiDeath serum levels were quantified in patient's sera.
RESULTS: Three hundred and thirty-one patients were screened and 211 patients could be included in this study. The median duration of follow-up was 322 days with a range of 1-1382 days. All three cell death parameters correlated with the extent of the severity of the disease. However, M65EpiDeath was the only of the three parameters which was associated with the severe complications of cirrhosis including ascites, spontaneous bacterial peritonitis and hepatorenal syndrome. Additionally, M65EpiDeath was the only cell death parameter which was independently from liver function and its surrogate parameter such as Child-Pugh score and the model of end-stage liver disease associated with overall survival.
CONCLUSIONS: Epithelial cell death reflected by M65EpiDeath serum levels is an indicator for the severity of cirrhosis and a prognostic survival parameter in cirrhotic patients.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  M30; M65; acute-on-chronic liver failure; cell death; cirrhosis

Mesh:

Substances:

Year:  2016        PMID: 26991828     DOI: 10.1111/liv.13117

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  6 in total

1.  Is Keratin-18 only a Marker of Cell Death in Acute-On-Chronic Liver Failure?

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  J Lab Precis Med       Date:  2018-03-20

2.  Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.

Authors:  Hani Oweira; Mahmoud Sadeghi; Daniel Volker; Markus Mieth; Ahmed Zidan; Elias Khajeh; Omid Ghamarnejad; Hamidreza Fonouni; Karl Heinz Weiss; Jan Schmidt; Imad Lahdou; Arianeb Mehrabi
Journal:  Ann Transplant       Date:  2018-06-08       Impact factor: 1.530

Review 3.  The fibrogenic process and the unleashing of acute-on-chronic liver failure.

Authors:  Guillermo Nahúm López-Sánchez; Mayra Dóminguez-Pérez; Misael Uribe; Natalia Nuño-Lámbarri
Journal:  Clin Mol Hepatol       Date:  2019-06-14

4.  Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.

Authors:  Fabian Finkelmeier; Özge Canli; Kai-Henrik Peiffer; Dirk Walter; Andrea Tal; Christine Koch; Ursula Pession; Johannes Vermehren; Jörg Trojan; Stefan Zeuzem; Albrecht Piiper; Florian R Greten; Georgios Grammatikos; Oliver Waidmann
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

5.  Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery.

Authors:  Gersina Rega-Kaun; Dorothea Ritzel; Christoph Kaun; Benjamin Ebenbauer; Barbara Thaler; Manfred Prager; Svitlana Demyanets; Johann Wojta; Philipp J Hohensinner
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

Review 6.  Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis.

Authors:  Si-Hai Chen; Qin-Si Wan; Ting Wang; Kun-He Zhang
Journal:  Biomed Res Int       Date:  2020-03-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.